subject: The Worldwide Market For Cancer Diagnostics, 4th Edition --- Aarkstore Enterprise [print this page] Since last updated our comprehensive market report on cancer testing, changes in the industry abound. Developments that were novel two years ago such as the commercialization of service products , PGx testing and tissue microarrays are showing an increased presence. Some companies who promised much in the past have not produced results. And new entrants have entered the field.
These changes and more are addressed in Worldwide Market for Cancer Diagnostics, 4th. Edition. This report authored by Kalorama Diagnostic Analyst Shara Rosen, contains detailed market data on the following IVD segments for their use in cancer diagnostics:
* Histology/Cytology
* Immunoassays
* Flow Cytometry
* Rapid Tests
* Molecular Assays
* Tissue Arrays
* Circulating Tumor Cells
* Pharmacodiagnostics
Diagnostic tests for effective cancer screening are obviously needed more than ever. As cancer becomes more treatable, diagnostics are finding multiple expanded roles, including pharmacodiagnostics for matching the targeted treatment to the patient and ongoing disease monitoring as treatable cancer enters the realm of the chronic disease. Worldwide Market for Cancer Diagnostics, 4th Edition represents the fourth time has engaged in an exhaustive study on the status of this important diagnostic market. Among the market data provided in this report, readers will find:
* Immunoassay Lab Based Cancer Test Sales
* Pap Smear Testing Volumes
* World Cancer Statistics
* POC Tests
* DNA Reagents for Cancer Testing
* CTC Testing Markets
* Biochip Innovations
* New Companies with Novel Approaches
* "Laggard" Companies Who Have Not Met Expectations
* Major Protein and Molecular Markers Used in Tissue Staining
* Biomarkers Under Investigation
* Acquisitions and Mergers
* Status of PGx Testing
* Microarray Markets in Clinical Labs
* Lists of Vendors and Major Products
* Unmet Needs of the Marketplace
This report includes market analysis of the following screening tests: The Cancer Profile, CTC, Fecal Occult Blood, PSA, H. pylori, IHC, ISH As well as tests for specific cancers:
* Bladder Cancer
* Breast Cancer
* Cervical Cancer
* Colon Cancer
* Lung Cancer
* Ovarian Cancer
* Prostate Cancer
This latest edition of study takes a fresh look at all of these developments both qualitatively and quantitatively. The report provides revenue and growth forecasts through 2014 and, as in the previous edition, analyzes the market in two ways:
* Tests for specific cancers, and
* Cancer tests in specific IVD segments
This allows the reader to match his or her own situation to the market at large.
In addition to extensive reviews of products on the market and in development in each segment, the report provides detailed company profiles.
